Gate2Health, a space for open innovation in healthcare, a benchmark for the innovation ecosystem&rdquo
TECNALIA joins the Gate2Health programme to promote open innovation in healthcare
TECNALIA has signed a Framework Collaboration Agreement with GSK, a leading biopharmaceutical company in the research and development of medicines and vaccines, to participate in its initiative called Innovation Lab, a programme of open innovation that seeks to generate disruptive solutions to improve patients’ lives.
The Gate2Health programme is as a collaborative hub where startups, technology companies, healthcare professionals and patient associations work together to identify challenges in the sector, share knowledge and develop projects that transform care models. In this ecosystem, TECNALIA will offer its technological capabilities, experience in applied research and strategic vision, consolidating its role as a European benchmark for innovation.
With more than 1,500 professionals and a solid track record in fields such as healthcare, TECNALIA will help to:
- Detect needs and opportunities in the healthcare sector
- Promote joint projects that respond to the challenges that are identified
- Explore synergies and new avenues of collaboration to accelerate solutions with real impact
Open Innovation
Gate2Health is a space for open innovation in healthcare and a new benchmark for the main stakeholders of the sector’s innovation ecosystem, from professionals and healthcare organisations and patients, to entrepreneurs and academic, sports and technological entities, among others.
Within this framework, TECNALIA seeks to address major challenges facing the healthcare system in order to contribute to its sustainable transformation and improve patients’ lives.
Bringing science, technology and talent together
Within the framework of this partnership, our objectives are:
- To transform technological research into prosperity
- To be the actors of change in companies and society, adapting them to the challenges of a constantly evolving future
- To work with high-impact projects to achieve effective transfer from R&D to the National Health System
- To act as a relevant actor so that the customer and, in this case, the patient, are at the heart of everything, as one of the pillars of TECNALIA.
What will we achieve together?
- Focused innovation: we will focus on improving adult prevention and transforming women’s health.
- Solutions with real impact: we will drive scalable solutions, beyond the pilot project, with key stakeholders in the health sector.
- Sustainable solutions over time: we will involve the Health System to ensure the future sustainability of the solutions that are promoted.
- Identification of new opportunities and challenges: we will create a space for networking to explore new trends, generate shared lines of collaboration and embrace new opportunities.
This agreement strengthens our commitment to open innovation and the creation of strategic partnerships that anticipate the future of healthcare.
Challenges and focal points of innovation
Gate2Health seeks to address a range of health challenges, such as disease prevention through vaccination and transforming women’s health.
Together with GSK, we will work to implement initiatives that improve people’s quality of life, from developing advanced technologies to exploring new models of collaboration.
Contact our expert team and find out how we are building the future of healthcare.